Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1636 AL 1650

Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide

Gadad BS, Britton GB, Rao KS.

J Alzheimers Dis. 2011;24 Suppl 2:223-32. doi: 10.3233/JAD-2011-110182.

Physical, occupational, speech and swallowing therapies and physical exercise in Parkinson's disease

Ransmayr G.

J Neural Transm (Vienna). 2011 May;118(5):773-81. doi: 10.1007/s00702-011-0622-9. Epub 2011 Apr 3.

Bicycling breaks the ice for freezers of gait

Snijders AH, Toni I, Ružička E, Bloem BR.

Mov Disord. 2011 Feb 15;26(3):367-71. doi: 10.1002/mds.23530. Epub 2011 Feb 1.

Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: clinicopathological case

Fabbrini G, Merello M, Evans AH, Lees AJ, Holton J, Williams DR.

Mov Disord. 2011 Feb 15;26(3):424-9. doi: 10.1002/mds.23302. Epub 2011 Jan 14.

Atypical juvenile parkinsonism in a consanguineous SPG15 family

Schicks J, Synofzik M, Pétursson H, Huttenlocher J, Reimold M, Schöls L, Bauer P.

Mov Disord. 2011 Feb 15;26(3):564-6. doi: 10.1002/mds.23472. Epub 2011 Jan 6.

Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial

Espay AJ, Dwivedi AK, Payne M, Gaines L, Vaughan JE, Maddux BN, Slevin JT, Gartner M, Sahay A, Revilla FJ, Duker AP, Shukla R.

Neurology. 2011 Apr 5;76(14):1256-62. doi: 10.1212/WNL.0b013e3182143537.

Diagnostic markers for Parkinson's disease

Chahine LM, Stern MB.

Curr Opin Neurol. 2011 Aug;24(4):309-17. doi: 10.1097/WCO.0b013e3283461723.

Oxidation chemistry of catecholamines and neuronal degeneration: an update

Napolitano A, Manini P, d'Ischia M.

Curr Med Chem. 2011;18(12):1832-45. doi: 10.2174/092986711795496863.

Dramatic response of dropped head sign to treatment with steroid in Parkinson's disease: report of three cases

Hemmi S, Kurokawa K, Izawa N, Kutoku Y, Murakami T, Sunada Y.

Intern Med. 2011;50(7):757-61. doi: 10.2169/internalmedicine.50.4395. Epub 2011 Apr 1.

Genetic marker linking inflammation with sporadic Parkinson's disease

Tan EK.

Ann Acad Med Singap. 2011 Feb;40(2):111-2.

PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease

Stocchi F, Giorgi L, Hunter B, Schapira AH.

Mov Disord. 2011 Jun;26(7):1259-65. doi: 10.1002/mds.23498. Epub 2011 Apr 5.

Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease

Merola A, Zibetti M, Angrisano S, Rizzi L, Lanotte M, Lopiano L.

Mov Disord. 2011 Mar;26(4):664-70. doi: 10.1002/mds.23524. Epub 2011 Apr 5.

Glycosidases in carbohydrate synthesis: when organic chemistry falls short

Bojarová P, Kren V.

Chimia (Aarau). 2011;65(1-2):65-70. doi: 10.2533/chimia.2011.65.

Mitochondria as a therapeutic target for aging and neurodegenerative diseases

Reddy PH, Reddy TP.

Curr Alzheimer Res. 2011 Jun;8(4):393-409. doi: 10.2174/156720511795745401.

Fuming over Parkinson disease: are welders at risk?

Martin WR.

Neurology. 2011 Apr 12;76(15):1286-7. doi: 10.1212/WNL.0b013e31821528ab. Epub 2011 Apr 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias